{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:23:35Z","timestamp":1775226215145,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The research grant of The Morinaga Hoshikai"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00246-022-03076-8","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T19:05:22Z","timestamp":1671735922000},"page":"1150-1159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utility of the Total Thrombus-Formation Analysis System as a Tool for Evaluating Thrombogenicity and Monitoring Antithrombotic Therapy in Pediatric Fontan Patients"],"prefix":"10.1007","volume":"44","author":[{"given":"Osamu","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiya","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"3076_CR1","doi-asserted-by":"publisher","first-page":"803408","DOI":"10.3389\/fped.2022.803408","volume":"10","author":"S Van Den Helm","year":"2022","unstructured":"Van Den Helm S, Sparks CN, Ignjatovic V, Monagle P, Attard C (2022) Increased risk for thromboembolism after Fontan surgery: considerations for thromboprophylaxis. Front Pediatr 10:803408. https:\/\/doi.org\/10.3389\/fped.2022.803408","journal-title":"Front Pediatr"},{"key":"3076_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1177\/1076029613520464","volume":"20","author":"M Firdouse","year":"2014","unstructured":"Firdouse M, Agarwal A, Chan AK, Mondal T (2014) Thrombosis and thromboembolic complications in Fontan patients: a literature review. Clin Appl Thromb Hemost 20:484\u2013492. https:\/\/doi.org\/10.1177\/1076029613520464","journal-title":"Clin Appl Thromb Hemost"},{"key":"3076_CR3","doi-asserted-by":"publisher","first-page":"e737S","DOI":"10.1378\/chest.11-2308","volume":"141","author":"P Monagle","year":"2012","unstructured":"Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, NowakG\u00f6ttl U, Vesely SK (2012) Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, ninth ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141:e737S-e801S. https:\/\/doi.org\/10.1378\/chest.11-2308","journal-title":"Chest"},{"key":"3076_CR4","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1161\/CIR.0000000000000603","volume":"139","author":"KK Stout","year":"2019","unstructured":"Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR et al (2019) 2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines. Circulation 139:e698\u2013e800. https:\/\/doi.org\/10.1161\/CIR.0000000000000603","journal-title":"Circulation"},{"key":"3076_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jacc.2011.01.061","volume":"58","author":"P Monagle","year":"2011","unstructured":"Monagle P, Cochrane A, Roberts R, Manlhiot C, Weintraub R, Szechtman B, Hughes M, Andrew M, Mccrindle BW (2011) Fontan anticoagulation study group, a multicenter, randomized trial comparing heparin\/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol 58:645\u2013651. https:\/\/doi.org\/10.1016\/j.jacc.2011.01.061","journal-title":"J Am Coll Cardiol"},{"key":"3076_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/ejcts\/ezu145","volume":"47","author":"H Ohuchi","year":"2015","unstructured":"Ohuchi H, Yasuda K, Miyazaki A, Ono S, Hayama Y, Negishi J, Noritake K et al (2015) Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics. Eur J Cardiothorac Surg 47:511\u2013519. https:\/\/doi.org\/10.1093\/ejcts\/ezu145","journal-title":"Eur J Cardiothorac Surg"},{"key":"3076_CR7","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1067\/mtc.2000.108903","volume":"120","author":"M Jahangiri","year":"2000","unstructured":"Jahangiri M, Kreutzer J, Zurakowski D, Bacha E, Jonas RA (2000) Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation. J Thorac Cardiovasc Surg 120:778\u2013782. https:\/\/doi.org\/10.1067\/mtc.2000.108903","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3076_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/hrt.2003.026419","volume":"91","author":"V Chaloupeck\u00fd","year":"2005","unstructured":"Chaloupeck\u00fd V, Svobodov\u00e1 I, Hada\u0107ov\u00e1 I, Tomek V, Hu\u010d\u00edn B, Tl\u00e1skal T, Janou\u0161ek J et al (2005) Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up. Heart 91:73\u201379. https:\/\/doi.org\/10.1136\/hrt.2003.026419","journal-title":"Heart"},{"key":"3076_CR9","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0003-4975(02)03580-4","volume":"73","author":"KC Odegard","year":"2002","unstructured":"Odegard KC, McGowan FX, Zurakowski D, DiNardo JA, Castro RA, del Nido PJ, Laussen PC (2002) Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg 73:1770\u20131777. https:\/\/doi.org\/10.1016\/S0003-4975(02)03580-4","journal-title":"Ann Thorac Surg"},{"key":"3076_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s00246-012-0431-4","volume":"34","author":"L Idorn","year":"2013","unstructured":"Idorn L, Jensen AS, Juul K, Reimers JI, Johansson PI, S\u00f8rensen KE, Ostrowski SR et al (2013) Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology. Pediatr Cardiol 34:262\u2013272. https:\/\/doi.org\/10.1007\/s00246-012-0431-4","journal-title":"Pediatr Cardiol"},{"key":"3076_CR11","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/j.1538-7836.2011.04464.x","volume":"9","author":"K Hosokawa","year":"2011","unstructured":"Hosokawa K, Ohnishi T, Kondo T, Fukasawa M, Koide T, Maruyama I, Tanaka KA (2011) A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions. J Thromb Haemost 9:2029\u20132037. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04464.x","journal-title":"J Thromb Haemost"},{"key":"3076_CR12","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1055\/s-0039-1693411","volume":"119","author":"K Kaikita","year":"2019","unstructured":"Kaikita K, Hosokawa K, Dahlen JR, Tsujita K (2019) Total Thrombus-Formation Analysis System (T-TAS): clinical application of quantitative analysis of thrombus formation in cardiovascular disease. Thromb Haemost 119:1554\u20131562. https:\/\/doi.org\/10.1055\/s-0039-1693411","journal-title":"Thromb Haemost"},{"key":"3076_CR13","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.3390\/ijms22168605","volume":"22","author":"J Sikora","year":"2021","unstructured":"Sikora J, Karczmarska-W\u00f3dzka A, Bugieda J, Sobczak P (2021) The use of total thrombus formation analysis system as a tool to assess platelet function in bleeding and thrombosis risk-a systematic review. Int J Mol Sci 22:8605. https:\/\/doi.org\/10.3390\/ijms22168605","journal-title":"Int J Mol Sci"},{"key":"3076_CR14","doi-asserted-by":"publisher","first-page":"e002744","DOI":"10.1161\/JAHA.115.002744","volume":"5","author":"M Ito","year":"2016","unstructured":"Ito M, Kaikita K, Sueta D, Ishii M, Oimatsu Y, Arima Y, Iwashita S et al (2016) Total Thrombus-Formation Analysis System (T-TAS) can predict periprocedural bleeding events in patients undergoing catheter ablation for atrial fibrillation. J Am Heart Assoc 5:e002744. https:\/\/doi.org\/10.1161\/JAHA.115.002744","journal-title":"J Am Heart Assoc"},{"key":"3076_CR15","doi-asserted-by":"publisher","first-page":"7399","DOI":"10.1038\/s41598-017-07939-6","volume":"7","author":"M Ishii","year":"2017","unstructured":"Ishii M, Kaikita K, Ito M, Sueta D, Arima Y, Takashio S, Izumiya Y et al (2017) Direct oral anticoagulants form thrombus different from warfarin in a microchip flow chamber system. Sci Rep 7:7399. https:\/\/doi.org\/10.1038\/s41598-017-07939-6","journal-title":"Sci Rep"},{"key":"3076_CR16","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1253\/circj.CJ-08-1087","volume":"73","author":"H Kajimoto","year":"2009","unstructured":"Kajimoto H, Nakazawa M, Murasaki K, Hagiwara N, Nakanishi T (2009) Increased P-selectin expression on platelets and decreased plasma thrombomodulin in Fontan patients. Circ J 73:1705\u20131710. https:\/\/doi.org\/10.1253\/circj.CJ-08-1087","journal-title":"Circ J"},{"key":"3076_CR17","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jtcvs.2013.06.011","volume":"147","author":"L Tomkiewicz-Pajak","year":"2014","unstructured":"Tomkiewicz-Pajak L, Hoffman P, Trojnarska O, Lipczy\u0144ska M, Podolec P, Undas A (2014) Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure. J Thorac Cardiovasc Surg 147:1284\u20131290. https:\/\/doi.org\/10.1016\/j.jtcvs.2013.06.011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3076_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1160\/TH12-06-0441","volume":"109","author":"K Hosokawa","year":"2013","unstructured":"Hosokawa K, Ohnishi T, Sameshima H, Miura N, Ito T, Koide T, Maruyama I (2013) Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions. Thromb Haemost 109:102\u2013111. https:\/\/doi.org\/10.1160\/TH12-06-0441","journal-title":"Thromb Haemost"},{"key":"3076_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12185-019-02782-z","volume":"111","author":"Y Nakajima","year":"2020","unstructured":"Nakajima Y, Nogami K, Yada K, Kawamura T, Ogiwara K, Furukawa S, Shimonishi N et al (2020) Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system. Int J Hematol 111:369\u2013377. https:\/\/doi.org\/10.1007\/s12185-019-02782-z","journal-title":"Int J Hematol"},{"key":"3076_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/ped.14378","volume":"63","author":"Y Nakajima","year":"2021","unstructured":"Nakajima Y, Yada K, Ogiwara K, Furukawa S, Shimonishi N, Shima M, Nogami K (2021) A microchip flow-chamber assay screens congenital primary hemostasis disorders. Pediatr Int 63:160\u2013167. https:\/\/doi.org\/10.1111\/ped.14378","journal-title":"Pediatr Int"},{"key":"3076_CR21","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1002\/ehf2.12824","volume":"7","author":"S Takashio","year":"2020","unstructured":"Takashio S, Kaikita K, Nishi M, Morioka M, Higo T, Shiose A, Doman T et al (2020) Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system. ESC Heart Fail 7:3235\u20133239. https:\/\/doi.org\/10.1002\/ehf2.12824","journal-title":"ESC Heart Fail"},{"key":"3076_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00246-009-9434-1","volume":"30","author":"L Raffini","year":"2009","unstructured":"Raffini L, Schwed A, Zheng XL, Tanzer M, Nicolson S, Gaynor JW, Jobes D (2009) Thromboelastography of patients after Fontan compared with healthy children. Pediatr Cardiol 30:771\u2013776. https:\/\/doi.org\/10.1007\/s00246-009-9434-1","journal-title":"Pediatr Cardiol"},{"key":"3076_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12959-021-00341-3","volume":"19","author":"Y Oda","year":"2021","unstructured":"Oda Y, Ito T, Yamada Y, Koga T, Nagasato T, Ohnishi-Wada T, Hosokawa K et al (2021) Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the total thrombus-formation analysis system. Thromb J 19:88. https:\/\/doi.org\/10.1186\/s12959-021-00341-3","journal-title":"Thromb J"},{"key":"3076_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.thromres.2013.05.026","volume":"132","author":"Y Yamaguchi","year":"2013","unstructured":"Yamaguchi Y, Moriki T, Igari A, Matsubara Y, Ohnishi T, Hosokawa K, Murata M (2013) Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals. Thromb Res 132:263\u2013270. https:\/\/doi.org\/10.1016\/j.thromres.2013.05.026","journal-title":"Thromb Res"},{"key":"3076_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1253\/circj.CJ-11-0540","volume":"76","author":"H Ohuchi","year":"2012","unstructured":"Ohuchi H, Ono S, Tanabe Y, Fujimoto K, Yagi H, Sakaguchi H, Miyazaki A, Yamada O (2012) Long-term serial aerobic exercise capacity and hemodynamic properties in clinically and hemodynamically good, \u201cexcellent.\u201d Fontan survivors Circ J 76:195\u2013203. https:\/\/doi.org\/10.1253\/circj.CJ-11-0540","journal-title":"Fontan survivors Circ J"},{"key":"3076_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijcard.2014.11.219","volume":"181","author":"L Tomkiewicz-Pajak","year":"2015","unstructured":"Tomkiewicz-Pajak L, Wojcik T, Ch\u0142opicki S, Olszowska M, Pajak J, Podolec J, Sitek B et al (2015) Aspirin resistance in adult patients after Fontan surgery. Int J Cardiol 181:19\u201326. https:\/\/doi.org\/10.1016\/j.ijcard.2014.11.219","journal-title":"Int J Cardiol"},{"key":"3076_CR27","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/CIRCULATIONAHA.116.023457","volume":"134","author":"J Patregnani","year":"2016","unstructured":"Patregnani J, Klugman D, Zurakowski D, Sinha P, Freishtat R, Berger J, Diab Y (2016) High on aspirin platelet reactivity in pediatric patients undergoing the Fontan procedure. Circulation 134:1303\u20131305. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023457","journal-title":"Circulation"},{"key":"3076_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ahj.2019.04.009","volume":"213","author":"LM Pina","year":"2019","unstructured":"Pina LM, Dong X, Zhang L, Samtani MN, Michelson AD, Justino H, Bonnet D et al (2019) Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: rationale and design of a prospective, randomized trial (the UNIVERSE study). Am Heart J 213:97\u2013104. https:\/\/doi.org\/10.1016\/j.ahj.2019.04.009","journal-title":"Am Heart J"},{"key":"3076_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/2150135119890555","volume":"11","author":"J Rychik","year":"2020","unstructured":"Rychik J, Dodds KM, Goldberg D, Glatz AC, Fogel M, Rossano J, Chen J et al (2020) Protein losing enteropathy after Fontan operation: glimpses of clarity through the lifting fog. World J Pediatr Congenit Heart Surg 11:92\u201396. https:\/\/doi.org\/10.1177\/2150135119890555","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"3076_CR30","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/S0003-4975(01)02472-9","volume":"71","author":"PD Coon","year":"2001","unstructured":"Coon PD, Rychik J, Novello RT, Ro PS, Gaynor JW, Spray TL (2001) Thrombus formation after the Fontan operation. Ann Thorac Surg 71:1990\u20131994. https:\/\/doi.org\/10.1016\/S0003-4975(01)02472-9","journal-title":"Ann Thorac Surg"},{"key":"3076_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/CIRCULATIONAHA.120.045597","volume":"142","author":"J Emamaullee","year":"2020","unstructured":"Emamaullee J, Zaidi AN, Schiano T, Kahn J, Valentino PL, Hofer RE, Taner T et al (2020) Fontan-associated liver disease: screening, management, and transplant considerations. Circulation 142:591\u2013604. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.045597","journal-title":"Circulation"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-022-03076-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-022-03076-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-022-03076-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T15:02:11Z","timestamp":1685199731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-022-03076-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3076"],"URL":"https:\/\/doi.org\/10.1007\/s00246-022-03076-8","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"assertion":[{"value":"16 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures were conducted in accordance with the Declaration of Helsinki and its amendments. The study protocol was approved by the human ethics committee of Kumamoto University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}